person · Reporting owner

McGorry James Joseph

Disclosed activity across 1 company

Tapewire entity: 165737
SEC CIK: 0001573147

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Harvard Apparatus Regenerative Technology, Inc.BSTG · Entity 7501	Director · Chief Executive Officer	June 12, 2018	June 14, 2018

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Harvard Apparatus Regenerative Technology, Inc.

Report date June 12, 2018 · Filed June 14, 2018

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	10,065	Reported balance After 2018-06-12 transaction · row 1 1 source row Row 1 · 2018-06-12 · Purchase · Acquired 2,100 · Balance 10,065

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 12, 2018 Filed Jun 14, 2018 23:22 UTC	Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501	PurchaseCommon Stock	2,100	$4.00	$8,400.00	Disclosure SEC source: 0001144204-18-034291 · tv496537_form4.xml · nonDerivative · entry 1 McGorry James Joseph · CIK 0001573147 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,065 Read SEC document
May 29, 2018 Filed Jun 1, 2018 00:23 UTC	Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501	GrantStock Option (right to buy) · Derivative	171,234	$0.00 Strike: $2.72	$0.00	Disclosure SEC source: 0001144204-18-032122 · tv495614_form4.xml · derivative · entry 2 McGorry James Joseph · CIK 0001573147 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,234 Underlying: Common Stock, par value $0.01 per share · 171,234 shares Expires 2028-05-29 F2 · derivative.exercise_date: Stock Option shares that vest in four equal installments on December 31, 2018, 2019, 2020 and 2021 (of the shares underlying this stock option grant, 147,056 shares are incentive stock options and 24,178 are non-qualified stock options). Read SEC document
May 29, 2018 Filed Jun 1, 2018 00:23 UTC	Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501	GrantStock Option (right to buy) · Derivative	171,233	$0.00 Strike: $2.72	$0.00	Disclosure SEC source: 0001144204-18-032122 · tv495614_form4.xml · derivative · entry 1 McGorry James Joseph · CIK 0001573147 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,233 Underlying: Common Stock, par value $0.01 per share · 171,233 shares Expires 2028-05-29 F1 · derivative.exercise_date: Non-Qualified Stock Option shares that vest based on certain performance milestones. Read SEC document
March 14, 2018 Filed Mar 28, 2018 21:08 UTC	Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501	Exercise / conversionRestricted Stock Units · Derivative	1,650	Not disclosed Strike: $0.00	Not disclosed	Disclosure SEC source: 0001144204-18-017592 · tv489775_form4.xml · derivative · entry 2 McGorry James Joseph · CIK 0001573147 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,950 Underlying: Common Stock · 1,650 shares Expires 2018-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit was the economic equivalent of one share of the Issuer's common stock. The reporting person settled the vested restricted stock units for shares of the Issuer's common stock. Read SEC document
March 14, 2018 Filed Mar 28, 2018 21:08 UTC	Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501	Exercise / conversionCommon Stock	1,650	Not disclosed	Not disclosed	Disclosure SEC source: 0001144204-18-017592 · tv489775_form4.xml · nonDerivative · entry 1 McGorry James Joseph · CIK 0001573147 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,965 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit was the economic equivalent of one share of the Issuer's common stock. The reporting person settled the vested restricted stock units for shares of the Issuer's common stock. Read SEC document
March 14, 2017 Filed Mar 16, 2017 20:16 UTC	Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501	GrantRestricted Stock Units · Derivative	132,000	$0.00	$0.00	Disclosure SEC source: 0001144204-17-015093 · v461953_4.xml · derivative · entry 2 McGorry James Joseph · CIK 0001573147 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,000 Underlying: Common Stock, par value $0.01 per share · 132,000 shares Expires not disclosed F2 · derivative.exercise_price: Restricted stock units granted by the Issuer pursuant to its 2013 Equity Incentive Plan and qualified under Rule 16b-3(d). Each restricted stock unit represents a contingent right to receive one share of Common Stock of the Issuer. F3 · derivative.exercise_date: The restricted stock units vest and settle in four equal installments on March 14, 2018, 2019, 2020 and 2021. F3 · derivative.expiration_date: The restricted stock units vest and settle in four equal installments on March 14, 2018, 2019, 2020 and 2021. Read SEC document
March 14, 2017 Filed Mar 16, 2017 20:16 UTC	Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501	GrantStock Option (right to buy) · Derivative	268,000	$0.00 Strike: $0.38	$0.00	Disclosure SEC source: 0001144204-17-015093 · v461953_4.xml · derivative · entry 1 McGorry James Joseph · CIK 0001573147 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,000 Underlying: Common Stock, par value $0.01 per share · 268,000 shares Expires 2027-03-14 F1 · derivative.exercise_date: The option shares vest in four equal installments on March 14, 2018, 2019, 2020 and 2021. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.